Loading candles…
Gujarat Themis Biosyn Ltd, incorporated in 1981, operates in the pharmaceutical industry, focusing on the manufacture and sale of finished Active Pharmaceutical Ingredients (APIs) using fermentation technology. The company produces APIs and intermediates through fermentation processes and primarily serves formulation manufacturers within the domestic market. Its notable activities include supplying critical raw materials for anti-tuberculosis and other therapeutic segments, expanding its fermentation capacities, and acquiring global brand portfolios to transition from a regional manufacturer to a global pharmaceutical player. No information is provided regarding its headquarters, founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for GUJARAT THEMIS BIOSYN LTD (GUJTHEM) on the NSE. As a listed security, GUJARAT THEMIS BIOSYN LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GUJTHEM before placing trades on tick2trade.
As of the latest feed, GUJTHEM last traded at ₹355.95 on NSE, down ₹5.95 (1.64%) from the previous close of ₹361.9. Today's session range is ₹341.65 – ₹382.2, against a 52-week band of ₹225.05 – ₹479. Traded volume today stands at 6.78L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for GUJTHEM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GUJTHEM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GUJARAT THEMIS BIOSYN LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GUJTHEM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GUJTHEM option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising | 7 Aug 2026 |
| Fund Raising | To consider Fund Raising | 19 Jun 2026 |
| Fund Raising | Gujarat Themis Biosyn Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on Jun 19, 2026 To con… | 19 Jun 2026 |
| Fund Raising | To consider Fund Raising and other business matters | 6 Jun 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, Recommending Dividend, If any, for the Financial year ended 31.03.2026; Co… | 25 May 2026 |
| Fund Raising | To consider Fund Raising | 25 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 10 Nov 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.